Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.68 USD | +2.53% | +26.10% | +76.82% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Neutral |
Resistance | 36.00 | 36.00 | 39.90 |
Spread/Res. | +1.58% | +1.58% | -8.35% |
Spread/Supp. | +37.22% | +72.74% | +174.76% |
Support | 26.65 | 21.17 | 13.31 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- RNAC Stock
- Charts Cartesian Therapeutics, Inc.